KALP YETERSİZLİĞİ VE BESLENME İLE İLİŞKİLİ FAKTÖRLER

Yıl 2020, Cilt: 29 Sayı: 1, 66 - 70, 04.05.2020

Hilal Toklu

https://doi.org/10.34108/eujhs.446752

Öz

Kalp
yetersizliği (KY) prevalansı yaşla birlikte artan ve çeşitli risk
faktörlerinden etkilenen bir sendromdur. Diyabet, obezite, hipertansiyon gibi
beslenme ile ilişkili metabolik hastalıklar kalp yetersizliğinin patogenezinde
önemli rol oynamaktadır. Hastalığın tedavisinde beslenme önerileri değişkenlik
göstermekle beraber genel olarak sodyumdan kısıtlı bir diyet önerilmektedir. Ancak
bu hastalarda diüretik ilaç kullanımına bağlı olarak farklı besin ögelerinde
yetersizlikler ve sonuç olarak malnütrisyon gözlenebilmektedir. Kalp yetersizliğinin
önlenebilmesi ya da semptomların düzeltilebilmesi için farklı diyetsel
yaklaşımlar uygulanıp, omega-3 ve yetersizliği görülen mikro besin ögeleri
takviye olarak verilebilir. Artan prevalansın bir sonucu olarak bu konuda
yapılan çalışmaların sayısı artmış olmasına karşın, beslenme önerileri
değişkenlik göstermektedir. 

Anahtar Kelimeler

beslenme, malnütrisyon, Kalp yetersizliği

Kaynakça

• 1. Franco J, Formiga F, Trullas JC, et al. Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure. Eur J Intern Med 2017; 43: 36–41
• 2. Dharmarajan K, Rich MW. Epidemiology, pathophysiology, and prognosis of heart failure in older adults. Heart Failure Clin 2017; (13): 417–426
• 3. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016; 37: 2129–2200
• 4. Akut ve kronik kalp yetersizliği tanı ve tedavisine yönelik 2012 ESC kılavuzu. Türk Kardiyol Dern Arş 2012; 3: 79-85
• 5. Metra M, Teerlink JR. Heart failure. Lancet 2017; 390: 1981–1995
• 6. Komanduri S, Jadhaoa Y, Gudurua SS, Cheriyatha PP, Wertb Y. Prevalence and risk factors of heart failure in the USA: NHANES 2013 – 2014 epidemiological follow-up study. J Community Hosp Intern Med Perspect 2017; 7(1): 15–20
• 7. Değertekin M, Erol Ç, Ergene O, ve ark. Türkiye’deki kalp yetersizliği prevelansı ve öngördürücüleri : HAPPY çalışması. Türk Kardiol Dern Arş 2012; 40(4): 298-308
• 8. Rich MW, Hauptman PJ. Nutrition in heart failure: More than drugs and devices. J Card Fail 2015; 21; 12: 943-944
• 9. Arcand J, Floras V, Ahmed M, et al. Nutritional inadequacies in patients with stable heart failure. J Am Diet Assoc 2009; 109: 1909-1913
• 10. DiNicolantonioa JJ, Chatterjeeb S, O’Keefea JH. Dietary salt restriction in heart failure: Where is the evidence? Prog Cardiovasc Dis 2016; 58: 401-406
• 11. Doukky R, Avery E, Mangla A, et al Impact of dietary sodium restriction on heart failure outcomes. JACC: Heart Fail 2016; 4(1): 24-35
• 12. Jeferson K, Ahmed M, Choleva M, et al Effect of a sodium-restricted diet on intake of other nutrients in heart failure: Implications for research and clinical practice. J Card Fail 2015; 21: 12
• 13. Arga Bermejo RM, Ferreiro RC, Román AV, et al. Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure. Int J Cardiol 2017; 230: 108–114
• 14. Bonilla-Palomas JL, Gamez-Lopez AL, Castillo-Domıngue JC, et al. Nutritional intervention in malnourished hospitalized patients with heart failure. Arch Med Res 2016; 47: 535-540
• 15. Helvacı A, Tipi FF, Belen E. Obeziteye bağlı kardiyovasküler hastalıklar. Okmeydanı Tıp Dergisi 2014; 30(1): 5-14
• 16. Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. J Am Coll Cardiol HF 2013; 1: 93–102
• 17. Kenchaiah S, Evans J, Levy D, et al. Obesity and the risk of heart failure. New England J Med. 2002; 347(5): 305–313
• 18. Ingelsson E, Sundström J, Arnlöv J, et al. Insulin re¬sistance and risk of congestive heart failure. JAMA 2005; 294(3): 334-341
• 19. Doukky R, Mangla A, Ibrahim Z. Impact of physical inactivity on mortality in patients with heart failure. Am J Cardiol 2016; 117: 1135-1143
• 20. Stanley WC, Dabkowski ER, Ribeiro RF, O’Connell KA. Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res 2012; 110: 764-776
• 21. Lennie TA, Chung ML, Habash DL, Moser DK. Dietary fat intake and proinflammatory cytokine levels in patients with heart failure J Card Fail 2005; 11(8): 613-618
• 22. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1223–1230
• 23. Chrysohoou C, Metallinos G, Georgiopoulos G. Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; A randomized clinical trial. Vasc Pharmacol 2016; 79: 43–50
• 24. Zeghichi-Hamri S, de Lorgeril M, Salen P, et al. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats, Nutr Res 2010; 30: 849–857
• 25. Lennie TA. Nutritional recommendations for patients with heart failure. J Cardiovasc Nurs 2006; 21(4): 261-268
• 26. Valentova M, von Haehling S, Doehner W. Liver dysfunction and its nutritional implications in heart failure. Nutr 2013; 29: 370–378
• 27. De Lorgeril M, Salen P, Accominotti M. et al. Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 2001; 3: 661–669
• 28. Adamopoulos C, Pitt B, Sui X. Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensity-matched study. Int J Cardiol 2009; 136: 270–277
• 29. DiNicolantonio JJ, Niazi AK, Lavie CJ, O’Keefe JH, Ventura HO. Thiamine supplementation for the treatment of heart failure: A review of the literature. Congest Heart Fail 2013; 19(4): 214-222
• 30. DiNicolantonio JJ, Lavie CJ, Niazi AK, O’Keefe JH, Hu T. Effects of thiamine on cardiac function in patients with systolic heart failure: Systematic review and metaanalysis of randomized, double-blind, placebo- controlled trials. Ochsner J 2013; 13: 495–499
• 31. Smithline HA. Thiamine for the treatment of acute decompensated heart failure. Am J Emerg Med 2007; 25: 124–131
• 32. Hughes CM, Woodside JV, McGartland C, et al. Nutritional intake and oxidative stress in chronic heart failure. Nutr Metab Cardiovasc Dis 2012; 22(4): 376-382
• 33. Lourenco BH, Vieira LP, Macedo A, et al. Nutritional status and adequacyof energy and nutrient intakes among heart failure patients. Arq Bras Cardiol 2009; 93(5): 541-548
• 34. Miró Ò, Estruch R, Martín-Sánchez FJ, et al. Adherence to mediterranean diet and all-cause mortality after an episode of acute heart failure. J Am Coll Cardiol HF 2018; 1: 52-62
• 35. Tektonidis TG, Åkesson A, Gigante B, Wolk A, Larsson SC. Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men. Eur J Heart Fail 2016; 18: 253–259
• 36. Rifaia L, Silverb MA. A Review of the DASH diet as an optimal dietary plan for symptomatic heart failure. Prog Cardiovasc Dis 2016; 58: 548-554
• 37. Levitan EB, Lewis CE, Tinker LF, et al. Mediterranean and DASH diet scores and mortality in women with heart failure. Circ Heart Fail 2013; 6: 1116-1123